Department of Biochemistry, Molecular Biology and Medicine, The George Washington University, NW, Washington, DC 20052, USA.
Metabolism. 2010 Sep;59(9):1372-8. doi: 10.1016/j.metabol.2009.12.025.
We previously showed that quercetin expresses its antiatherogenic effects by up-regulating paraoxonase 1 (PON1) gene and high-density lipoprotein's protective capacity against low-density lipoprotein oxidation. In an attempt to elucidate the mechanism of action of quercetin, we have now determined the effects of quercetin on PON1 gene expression, activity, protein level, nuclear mature sterol regulatory element binding protein 2 (SREBP2) level, and its translocation from the endoplasmic reticulum to nucleus and its interaction with PON1 promoter in human HuH7 liver cells using real-time reverse transcriptase polymerase chain reaction, spectrophotometry, immunoblot, confocal microscopy, and electrophoretic mobility shift assay techniques, respectively. Quercetin (20 micromol/L) treatment increased PON1 messenger RNA by 75% (P < .02), with a concomitant 2-fold (P < .05) increase in PON1 activity accompanied by 60% (P < .01) increase in PON1 protein level. There was parallel to the 1.5- to 2.0-fold increase (P < .05) in mature SREBP2 in the cell nuclei that was verified by increased immunolocalization of the mature SREBP2 (65-kd species) in the nuclei of quercetin-treated cells by confocal microscopy. Evaluation of the binding of biotin-labeled sterol responsive element (SRE)-like element of the PON1 promoter to the nuclear extract from the 24-hour quercetin (20 micromol/L)-treated HuH7 cells by electrophoretic mobility shift assay revealed that the SREBP2 specifically binds to the SRE-like element that was abolished by prior incubation with anti-SREBP2 or significantly decreased by 200-fold molar excess of unlabeled SRE-like sequence. Based on these results, we conclude that quercetin exhibits its antiatherogenic property by eliciting the translocation of the mature SREBP2 from endoplasmic reticulum to the nucleus, where it binds to SRE-like sequence in the PON1 promoter and up-regulates PON1 gene transcription and PON1 activity.
我们之前的研究表明,槲皮素通过上调对氧磷酶 1(PON1)基因和高密度脂蛋白(HDL)对低密度脂蛋白(LDL)氧化的保护能力来发挥其抗动脉粥样硬化作用。为了阐明槲皮素的作用机制,我们现在已经使用实时逆转录聚合酶链反应、分光光度法、免疫印迹、共聚焦显微镜和电泳迁移率变动分析技术,分别确定了槲皮素对 PON1 基因表达、活性、蛋白水平、核成熟固醇调节元件结合蛋白 2(SREBP2)水平以及其从内质网到核的易位及其与 PON1 启动子的相互作用。槲皮素(20 微摩尔/升)处理使 PON1 信使 RNA 增加了 75%(P <.02),同时 PON1 活性增加了 2 倍(P <.05),PON1 蛋白水平增加了 60%(P <.01)。细胞核中成熟的 SREBP2 平行增加了 1.5 到 2 倍(P <.05),这通过共聚焦显微镜证实了用槲皮素处理的细胞核中成熟的 SREBP2(65kD 种)的免疫定位增加。通过电泳迁移率变动分析评估生物素标记的固醇反应元件(SRE)样元件与来自 24 小时槲皮素(20 微摩尔/升)处理的 HuH7 细胞的核提取物的结合,结果表明 SREBP2 特异性结合 SRE 样元件,该元件被预先用抗 SREBP2 孵育所废除,或被 200 倍摩尔过量的未标记 SRE 样序列显著降低。基于这些结果,我们得出结论,槲皮素通过诱导成熟的 SREBP2 从内质网易位到细胞核,在那里它与 PON1 启动子中的 SRE 样序列结合并上调 PON1 基因转录和 PON1 活性,从而发挥其抗动脉粥样硬化作用。